Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002480914 | SCV002783459 | uncertain significance | Mitochondrial complex 1 deficiency, nuclear type 16 | 2022-03-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002537856 | SCV003564468 | uncertain significance | Inborn genetic diseases | 2022-06-24 | criteria provided, single submitter | clinical testing | The c.617C>T (p.T206M) alteration is located in exon 7 (coding exon 7) of the NDUFAF5 gene. This alteration results from a C to T substitution at nucleotide position 617, causing the threonine (T) at amino acid position 206 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
3billion | RCV002480914 | SCV005328733 | likely benign | Mitochondrial complex 1 deficiency, nuclear type 16 | 2024-09-20 | criteria provided, single submitter | clinical testing | The homozygous variant was found in patients diagnosed with another variant in a different gene, with no symptoms related to the gene containing the homozygous variant. |
Natera, |
RCV001279573 | SCV001466670 | uncertain significance | Leigh syndrome | 2020-05-25 | no assertion criteria provided | clinical testing |